受胎能検査の世界市場2021年-2028年:製品別(排卵予測キット、不妊治療モニター、男性不妊治療製品)、購入方法別、用途別、エンドユーザー別

■ 英語タイトル:Fertility Test Market by Product (Ovulation Prediction Kits, Fertility Monitors, and Male Fertility Testing Products), Mode of Purchase (OTC-based and Prescription-based), Application (Female Fertility Testing and Male Fertility Testing), and End User (Home Care Settings and Hospitals/Fertility Clinics): Global Opportunity Analysis and Industry Forecast, 2021–2028

調査会社Allied Market Research社が発行したリサーチレポート(データ管理コード:AMR21JU078)■ 発行会社/調査会社:Allied Market Research
■ 商品コード:AMR21JU078
■ 発行日:2021年5月31日
■ 調査対象地域:グローバル
■ 産業分野:医療
■ ページ数:220
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single UserUSD6,168 ⇒換算¥912,864見積依頼/購入/質問フォーム
5 UserUSD6,929 ⇒換算¥1,025,492見積依頼/購入/質問フォーム
Enterprise UserUSD9,663 ⇒換算¥1,430,124見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[受胎能検査の世界市場2021年-2028年:製品別(排卵予測キット、不妊治療モニター、男性不妊治療製品)、購入方法別、用途別、エンドユーザー別]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

本調査資料では、受胎能検査の世界市場について調査し、イントロダクション、エグゼクティブサマリー、市場状況、製品別(排卵予測キット、受胎能モニター、男性用受胎能検査製品)分析、購入方法別(OTCベース受胎能検査、処方ベース受胎能検査)分析、用途別(女性用受胎能検査、男性用受胎能検査)分析、地域別分析、企業情報などを掲載しています。
・イントロダクション
・エグゼクティブサマリー
・市場状況
・受胎能検査の世界市場規模:製品別(排卵予測キット、受胎能モニター、男性用受胎能検査製品)
・受胎能検査の世界市場規模:購入方法別(OTCベース受胎能検査、処方ベース受胎能検査)
・受胎能検査の世界市場規模:用途別(女性用受胎能検査、男性用受胎能検査)
・受胎能検査の世界市場規模:地域別
・企業情報

Fertility testing is a medical and physical testing assessment that tests the ability to naturally conceive. The fertility test includes the testing of the both the genders. The female fertility testing includes the testing of urine or saliva for the presence of ovulatory hormones. The hormones tested for the presence include luteinizing hormone, estrogen, and progesterone. On the other hand, the male fertility testing includes the testing of the semen for sperm count.

The global fertility testing market was valued at $462.23 million in 2020, and is projected to reach $842.96 million by 2028, registering a CAGR of 7.8%. This market growth is attributed to rise in the prevalence of diseases such as PCOS because women with the condition of PCOS do not ovulate every month regularly due to the overproduction of estrogen by the ovaries. Furthermore, increase in number of first-time pregnancies in women and decline in fertility rates across the globe drive the market growth. In addition, growth in awareness regarding fertility testing in both developed and developing countries boosts the market growth. Moreover, the launch of technologically advanced products with high accuracy further drives the market during the forecast period. For instance, in June 2020, Modern Fertility has launched its two new products, Modern Fertility Pregnancy Test, Ovulation Test and free Modern Fertility App.

On the other hand, shift in preference of patients toward at-home fertility tests, owing to availability of easy-to-use ovulation prediction test kits and surge in market strategies such as product development and innovation by key players are expected to offer profitable opportunities for growth of the market during the forecast period.

The global fertility test market is segmented on the basis of the product, mode of purchase, application, end user, and region. By product, the market is categorized into ovulation prediction kits, fertility monitors, and male fertility testing products. The fertility monitors segment is further divided into urine-based ovulation kits, saliva-based ovulation kits, and other fertility monitors. By mode of purchase, it is bifurcated into OTC-based and prescription-based. By application, it is fragmented into female fertility testing and male fertility testing. By end user, it is bifurcated into home care settings and fertility clinics. Region wise the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
 This report provides a detailed quantitative analysis of the current market trends and future estimations from 2021 to 2028, which assists to identify the prevailing market opportunities.
 An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
 A comprehensive analysis of the factors that drive and restrain the growth of the hemodialysis and peritoneal dialysis market is provided.
 An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS
By Product
o Ovulation Prediction Kits
o Fertility Monitors
 Urine-based Ovulation Kits
 Saliva-based Ovulation Kit
 Other Fertility Monitors
o Male Fertility Testing Products

By Mode of Purchase
o OTC-based
o Prescription-based

By Application
o Female Fertility Testing
o Male Fertility Testing

By End User
o Home Care Settings
o Fertility Clinics

By Region
o North America
 U.S.
 Canada
 Mexico
o Europe
 Germany
 UK
 France
 Italy
 Spain
 Rest of Europe
o Asia-Pacific
 Japan
 China
 India
 Australia
 South Korea
 Rest of Asia-Pacific
o LAMEA
 Brazil
 Saudi Arabia
 South Africa
 Rest of LAMEA

KEY MARKET PLAYERS
• Church & Dwight Co. Inc.
• Fairhaven Health LLC
• Fertility Focus Limited
• Geratherm Medical AG
• HiLin Life Products Inc.
• Prestige Brands Holdings Inc.
• Quidel Corporation
• Abbott Laboratories
• UEBE Medical
• Advacare Pharma

*** レポート目次(コンテンツ)***

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Declining fertility rates across the globe
3.5.1.2.Increasing awareness of fertility testing
3.5.1.3.Launch of technologically advanced products with high accuracy

3.5.2.Restraint

3.5.2.1.Unproven accuracy of ovulation monitors in PCOS/PCOD patients
3.5.2.2.High cost of fertility testing monitors

3.5.3.Opportunities

3.5.3.1.Sales of fertility testing devices on online platform
3.5.3.2.Growth opportunities in emerging countries

3.5.4.Impact analysis

3.6.COVID-19 Impact Analysis on fertility test Market

CHAPTER 4:FERTILITY TEST MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Ovulation Prediction Kits

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Fertility monitors

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.3.4.Market size and forecast, by type
4.3.5.Urine based ovulation kits

4.3.5.1.Market size and forecast

4.3.6.Saliva based ovulation kits

4.3.6.1.Market size and forecast

4.3.7.Other fertility monitors

4.3.7.1.Market size and forecast

4.4.Male fertility testing products

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country

CHAPTER 5:FERTILITY TEST MARKET, BY MODE OF PURCHASE

5.1.Overview

5.1.1.Market size and forecast

5.2.OTC based fertility test

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Prescription based fertility test

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

CHAPTER 6:FERTILITY TEST MARKET, BY APPLICATION

6.1.Overview

6.1.1.Market size and forecast

6.2.Female fertility testing

6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country

6.3.Male fertility testing

6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country

CHAPTER 7:FERTILITY TEST MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country

7.2.2.1.U.S.

7.2.2.1.1.U.S. Fertility Test Market, by product
7.2.2.1.2.U.S. Fertility Test market, by application
7.2.2.1.3.U.S. Fertility Test Market, by distribution channel

7.2.2.2.Canada

7.2.2.2.1.Canada Fertility Test Market, by product
7.2.2.2.2.Canada Fertility Test Market, by application
7.2.2.2.3.Canada Fertility Test Market, by distribution channel

7.2.2.3.Mexico

7.2.2.3.1.Mexico Fertility Test Market, by product
7.2.2.3.2.Mexico Fertility Test Market, by application
7.2.2.3.3.Mexico Fertility Test Market, by distribution channel

7.2.3.North America market size and forecast, by product
7.2.4.North America market size and forecast, by application
7.2.5.North America market size and forecast, by distribution channel

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country

7.3.2.1.Germany

7.3.2.1.1.Germany Fertility Test Market, by product
7.3.2.1.2.Germany Fertility Test Market, by application
7.3.2.1.3.Germany Fertility Test Market, by distribution channel

7.3.2.2.France

7.3.2.2.1.France Fertility Test Market, by product
7.3.2.2.2.France Fertility Test Market, by application
7.3.2.2.3.France Fertility Test Market, by distribution channel

7.3.2.3.UK

7.3.2.3.1.UK Fertility Test Market, by product
7.3.2.3.2.UK Fertility Test Market, by application
7.3.2.3.3.UK Fertility Test Market, by distribution channel

7.3.2.4.Italy

7.3.2.4.1.Italy Fertility Test Market, by product
7.3.2.4.2.Italy Fertility Test Market, by application
7.3.2.4.3.Italy Fertility Test Market, by distribution channel

7.3.2.5.Spain

7.3.2.5.1.Spain Fertility Test Market, by product
7.3.2.5.2.Spain Fertility Test Market, by application
7.3.2.5.3.Spain Fertility Test Market, by distribution channel

7.3.2.6.Rest of Europe

7.3.2.6.1.Rest of Europe Fertility Test Market, by product
7.3.2.6.2.Rest of Europe Fertility Test Market, by application
7.3.2.6.3.Rest of Europe Fertility Test Market, by distribution channel

7.3.3.Europe market size and forecast, by product
7.3.4.Europe market size and forecast, by application
7.3.5.Europe market size and forecast, by distribution channel

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country

7.4.2.1.Japan

7.4.2.1.1.Japan Fertility Test Market, by product
7.4.2.1.2.Japan Fertility Test Market, by application
7.4.2.1.3.Japan Fertility Test Market, by distribution channel

7.4.2.2.China

7.4.2.2.1.China Fertility Test Market, by product
7.4.2.2.2.China Fertility Test Market, by application
7.4.2.2.3.China Fertility Test Market, by distribution channel

7.4.2.3.Australia

7.4.2.3.1.Australia Fertility Test Market, by product
7.4.2.3.2.Australia Fertility Test Market, by application
7.4.2.3.3.Australia Fertility Test Market, by distribution channel

7.4.2.4.India

7.4.2.4.1.India Fertility Test Market, by product
7.4.2.4.2.India Fertility Test Market, by application
7.4.2.4.3.India Fertility Test Market, by distribution channel

7.4.2.5.South Korea

7.4.2.5.1.South Korea Fertility Test Market, by product
7.4.2.5.2.South Korea Fertility Test Market, by application
7.4.2.5.3.South Korea Fertility Test Market, by distribution channel

7.4.2.6.Rest of Asia-Pacific

7.4.2.6.1.Rest of Asia-Pacific Fertility Test Market, by product
7.4.2.6.2.Rest of Asia-Pacific Fertility Test Market, by application
7.4.2.6.3.Rest of Asia-Pacific Fertility Test Market, by distribution channel

7.4.3.Asia-Pacific market size and forecast, by product
7.4.4.Asia-Pacific market size and forecast, by application
7.4.5.Asia-Pacific market size and forecast, by distribution channel

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country

7.5.2.1.Brazil

7.5.2.1.1.Brazil Fertility Test Market, by product
7.5.2.1.2.Brazil Fertility Test Market, by application
7.5.2.1.3.Brazil Fertility Test Market, by distribution channel

7.5.2.2.Saudi Arabia

7.5.2.2.1.Saudi Arabia Fertility Test Market, by product
7.5.2.2.2.Saudi Arabia Fertility Test Market, by application
7.5.2.2.3.Saudi Arabia Fertility Test Market, by distribution channel

7.5.2.3.South Africa

7.5.2.3.1.South Africa Fertility Test Market, by product
7.5.2.3.2.South Africa Fertility Test Market, by application
7.5.2.3.3.South Africa Fertility Test Market, by distribution channel

7.5.2.4.Rest of LAMEA

7.5.2.4.1.Rest of LAMEA Fertility Test Market, by product
7.5.2.4.2.Rest of LAMEA Fertility Test Market, by application
7.5.2.4.3.Rest of LAMEA Fertility Test Market, by distribution channel

7.5.3.LAMEA market size and forecast, by product
7.5.4.LAMEA market size and forecast, by application
7.5.5.LAMEA market size and forecast, by distribution channel

CHAPTER 8:COMPANY PROFILES

8.1.Church & Dwight Co., Inc.

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments

8.2.Fairhaven Health LLC

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments

8.3.Fertility Focus Limited

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments

8.4.Geratherm Medical AG

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments

8.5.Hilin Life Products Inc.

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Product portfolio
8.5.4.Business performance
8.5.5.Key strategic moves and developments

8.6.Prestige Consumer Healthcare Inc. (Prestige Brands Holdings Inc.)

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments

8.7.Quidel Corporation

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments

8.8.Abbott Laboratories

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments

8.9.UEBE Medical

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Product portfolio
8.9.4.Business performance
8.9.5.Key strategic moves and developments

8.10.AdvaCare Pharma

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments

LIST OF TABLES

TABLE 01.GLOBAL FERTILITY TEST MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 02.FERTILITY TEST MARKET FOR OVULATION PREDICTION KITS, BY REGION, 2020–2028 ($MILLION)
TABLE 03.FERTILITY TEST MARKET FOR FERTILITY MONITORS, BY REGION, 2020–2028 ($MILLION)
TABLE 04.FERTILITY TEST MARKET FOR FERTILITY MONITORS, BY TYPE, 2020–2028, ($MILLION)
TABLE 05.FERTILITY TEST MARKET FOR MALE FERTILITY TEST, BY REGION, 2020–2028 ($MILLION)
TABLE 06.GLOBAL FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2020–2028 ($MILLION)
TABLE 07.FERTILITY TEST MARKET FOR OTC BASED FERTILITY TEST, BY REGION, 2020–2028 ($MILLION)
TABLE 08.FERTILITY TEST MARKET FOR PRESCRIPTION BASED FERTILITY TEST, BY REGION, 2020–2028 ($MILLION)
TABLE 09.GLOBAL FERTILITY TEST MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 10.FERTILITY TEST MARKET FOR FEMALE FERTILITY TEST, BY REGION, 2020–2028 ($MILLION)
TABLE 11.FERTILITY TEST MARKET FOR MALE FERTILITY TEST, BY REGION, 2020–2028 ($MILLION)
TABLE 12.FERTILITY TEST MARKET, BY REGION, 2020-2028 ($MILLION)
TABLE 13.NORTH AMERICA FERTILITY TEST MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 14.U.S. FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 15.U.S. FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 16.U.S. FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 17.CANADA FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 18.CANADA FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 19.CANADA FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 20.MEXICO FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 21.MEXICO FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 22.MEXICO FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 23.NORTH AMERICA FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 24.NORTH AMERICA FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 25.NORTH AMERICA FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 26.EUROPE FERTILITY TEST MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 27.GERMANY FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 28.GERMANY FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 29.GERMANY FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 30.FRANCE FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 31.FRANCE FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 32.FRANCE FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 33.UK FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 34.UK FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 35.UK FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 36.ITALY FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 37.ITALY FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 38.ITALY FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 39.SPAIN FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 40.SPAIN FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 41.SPAIN FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 42.REST OF EUROPE FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 43.REST OF EUROPE FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 44.REST OF EUROPE FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 45.EUROPE FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 46.EUROPE FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 47.EUROPE FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 48.ASIA-PACIFIC FERTILITY TEST MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 49.JAPAN FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 50.JAPAN FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 51.JAPAN FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 52.CHINA FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 53.CHINA FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 54.CHINA FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 55.AUSTRALIA FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 56.AUSTRALIA FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 57.AUSTRALIA FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 58.INDIA FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 59.INDIA FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 60.INDIA FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 61.SOUTH KOREA FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 62.SOUTH KOREA FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 63.SOUTH KOREA FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 64.REST OF ASIA-PACIFIC FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 65.REST OF ASIA-PACIFIC FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 66.REST OF ASIA-PACIFIC FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 67.ASIA-PACIFIC FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 68.ASIA-PACIFIC FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 69.ASIA-PACIFIC FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 70.LAMEA FERTILITY TEST MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 71.LAMEA FERTILITY TEST MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 72.BRAZIL FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 73.BRAZIL FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 74.BRAZIL FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 75.SAUDI ARABIA FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 76.SAUDI ARABIA FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 77.SAUDI ARABIA FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 78.SOUTH AFRICA FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 79.SOUTH AFRICA FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 80.SOUTH AFRICA FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 81.REST OF LAMEA FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 82.REST OF LAMEA FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 83.REST OF LAMEA FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 84.LAMEA FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 85.LAMEA FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 86.LAMEA FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 87.CHURCH & DWIGHT CO., INC.: COMPANY SNAPSHOT
TABLE 88.CHURCH & DWIGHT CO., INC.: OPERATING SEGMENTS
TABLE 89.CHURCH & DWIGHT CO., INC.: PRODUCT PORTFOLIO
TABLE 90.CHURCH & DWIGHT CO., INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 91.FAIRHAVEN HEALTH LLC: COMPANY SNAPSHOT
TABLE 92.FAIRHAVEN HEALTH LLC: OPERATING SEGMENTS
TABLE 93.FAIRHAVEN HEALTH LLC: PRODUCT PORTFOLIO
TABLE 94.FAIRHAVEN HEALTH LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 95.FERTILITY FOCUS LIMITED: COMPANY SNAPSHOT
TABLE 96.FERTILITY FOCUS LIMITED: OPERATING SEGMENTS
TABLE 97.FERTILITY FOCUS LIMITED: PRODUCT PORTFOLIO
TABLE 98.FERTILITY FOCUS LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 99.GERATHERM MEDICAL AG: COMPANY SNAPSHOT
TABLE 100.GERATHERM MEDICAL AG: OPERATING SEGMENTS
TABLE 101.GERATHERM MEDICAL AG: PRODUCT PORTFOLIO
TABLE 102.GERATHERM MEDICAL AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 103.HILIN LIFE PRODUCTS INC: COMPANY SNAPSHOT
TABLE 104.HILIN LIFE PRODUCTS INC: PRODUCT PORTFOLIO
TABLE 105.HILIN LIFE PRODUCTS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 106.PRESTIGE CONSUMER HEALTHCARE INC: COMPANY SNAPSHOT
TABLE 107.PRESTIGE CONSUMER HEALTHCARE INC: OPERATING SEGMENTS
TABLE 108.PRESTIGE CONSUMER HEALTHCARE INC: PRODUCT PORTFOLIO
TABLE 109.PRESTIGE CONSUMER HEALTHCARE INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 110.QUIDEL CORPORATION: COMPANY SNAPSHOT
TABLE 111.QUIDEL CORPORATION: OPERATING SEGMENTS
TABLE 112.QUIDEL CORPORATION: PRODUCT PORTFOLIO
TABLE 113.QUIDEL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 114.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 115.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 116.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 117.ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 118.UEBE MEDICAL: COMPANY SNAPSHOT
TABLE 119.UEBE MEDICAL: PRODUCT PORTFOLIO
TABLE 120.UEBE MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 121.ADVACARE PHARMA: COMPANY SNAPSHOT
TABLE 122.ADVACARE PHARMA: OPERATING SEGMENTS
TABLE 123.ADVACARE PHARMA: PRODUCT PORTFOLIO
TABLE 124.ADVACARE PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 01.GLOBAL FERTILITY TEST MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2020-2028
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2028
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2020-2028
FIGURE 01.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 02.MODERATE BARGAINING POWER OF BUYERS
FIGURE 03.HIGH THREAT OF SUBSTITUTES
FIGURE 04.MODERATE THREAT OF NEW ENTRANTS
FIGURE 05.HIGH INTENSITY OF RIVALRY
FIGURE 06.TOP PLAYER POSITIONING, 2020
FIGURE 07.IMPACT ANALYSIS
FIGURE 08.COMPARATIVE ANALYSIS OF OVULATION PREDICTION KITS FERTILITY TEST MARKET, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 09.COMPARATIVE ANALYSIS OF FERTILITY MONITORS FERTILITY TEST MARKET, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 10.URINE BASED OVULATION KITS MARKET, 2020–2028, ($MILLION)
FIGURE 11.SALIVA BASED OVLATION KIT, 2020–2028, ($MILLION)
FIGURE 12.URINE BASED OVULATION KITS MARKET, 2020–2028, ($MILLION)
FIGURE 13.COMPARATIVE ANALYSIS OF MALE FERTILITY TESTING PRODUCTS FERTILITY TEST MARKET, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF FERTILITY TEST MARKET FOR OTC BASED FERTILITY TEST, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF FERTILITY TEST MARKET FOR PRESCRIPTION BASED FERTILITY TEST, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF FERTILITY TEST MARKET FOR FEMALE FERTILITY TEST, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF FERTILITY TEST MARKET FOR MALE FERTILITY TEST, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 18.CHURCH & DWIGHT CO., INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 19.CHURCH & DWIGHT CO., INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 20.GERATHERM MEDICAL AG: NET SALES, 2018–2020 ($MILLION)
FIGURE 21.GERATHERM MEDICAL AG: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 22.GERATHERM MEDICAL AG: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 23.PRESTIGE CONSUMER HEALTHCARE INC: NET SALES, 2018–2020 ($MILLION)
FIGURE 24.PRESTIGE CONSUMER HEALTHCARE INC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 25.PRESTIGE CONSUMER HEALTHCARE INC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 26.QUIDEL CORPORATION: NET SALES, 2018–2020 ($MILLION)
FIGURE 27.QUIDEL CORPORATION: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 28.ABBOTT LABORATORIES: NET SALES, 2018–2020 ($MILLION)
FIGURE 29.ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 30.ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2020 (%)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(AMR21JU078 )"受胎能検査の世界市場2021年-2028年:製品別(排卵予測キット、不妊治療モニター、男性不妊治療製品)、購入方法別、用途別、エンドユーザー別" (英文:Fertility Test Market by Product (Ovulation Prediction Kits, Fertility Monitors, and Male Fertility Testing Products), Mode of Purchase (OTC-based and Prescription-based), Application (Female Fertility Testing and Male Fertility Testing), and End User (Home Care Settings and Hospitals/Fertility Clinics): Global Opportunity Analysis and Industry Forecast, 2021–2028)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。